Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.10
-0.11 (-0.52%)
Nov 21, 2024, 1:18 PM EST - Market open
KNSA Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$36.60
Upside
+73.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +89.57% | Nov 5, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +65.88% | Oct 30, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +89.57% | Sep 13, 2024 |
| Wedbush | Wedbush | Buy Maintains $30 → $34 | Buy | Maintains | $30 → $34 | +61.14% | Jul 23, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $34 | Buy | Initiates | $34 | +61.14% | May 3, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $26 → $30 | Buy | Maintains | $26 → $30 | +42.18% | May 1, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $25 → $30 | Buy | Maintains | $25 → $30 | +42.18% | Apr 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | +18.48% | Jan 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $32 | Strong Buy | Maintains | $22 → $32 | +51.66% | Jul 26, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | -5.21% | Mar 9, 2023 |
| B of A Securities | B of A Securities | Strong Buy Maintains $37 → $34 | Strong Buy | Maintains | $37 → $34 | +61.14% | Dec 29, 2021 |
| B of A Securities | B of A Securities | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +18.48% | Apr 1, 2020 |
| JMP Securities | JMP Securities | Buy Maintains $44 → $35 | Buy | Maintains | $44 → $35 | +65.88% | Aug 14, 2019 |
| JMP Securities | JMP Securities | Buy Maintains $33 → $44 | Buy | Maintains | $33 → $44 | +108.53% | Sep 17, 2018 |